$11.60 $0.19 per serving
Product analysis
Calcium Hydroxyapatite Caps provide calcium that may help fill a dietary gap affecting normal bone mineral needs, with phosphorus in the same clearly identified source.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality100
Calcium and phosphorus come from clearly identified hydroxyapatite sources. The calcium form has good absorption potential.
Ingredient Transparency100
Both mineral amounts and their forms are disclosed. That makes the serving straightforward to identify and compare.
Value For Money100
The low cost per serving supports good value for both minerals. The clearly identified sources make comparisons with similar supplements easier.
Customer Satisfaction91
Customer feedback is very positive across thousands of ratings. The large review base provides an established picture of satisfaction.
Product Focus77
The clearest role is supplying calcium for normal bone mineral needs when intake is low. Total calcium intake includes food, and the available findings do not establish reliable fracture prevention.
- Format
Capsule - Container
- 120 Capsule(s)
- Per serving
- $0.19
- Customer rating
- 4.8 · 6,997 ratings
Goals
Impact
High effect
Phosphorus · 200 mgCalcium · 500 mg
Calcium supplies mineral for normal bone mineralization and can fill a dietary intake gap. Its serving amount is not a target for supplemental intake, and fracture results are mixed. The magnesium claim remains unresolved because the ingredient inventory lacks a matching declaration.
How this product is rated for Bone Health
Ingredient fit80
The ingredients keep the formula focused, though it may be linked to other health uses.
Goal fit
The ingredients keep the formula focused, though it may be linked to other health uses.
Dose adequacy
The disclosed amounts only partly meet the saved comparison ranges; small or unresolved amounts limit this finding.
Pathways40
The strongest recorded connection concerns bone mineral supply, without proving improved bone density or fewer fractures.
Depth
The strongest recorded connection concerns bone mineral supply, without proving improved bone density or fewer fractures.
Breadth
Only part of the selected bone mechanisms reaches the saved coverage threshold.
Evidence100
Calcium leads the saved evidence finding; its nutritional or preparation-specific limits still apply.
Evidence strength
Calcium leads the saved evidence finding; its nutritional or preparation-specific limits still apply.
Studied preparation
The saved findings recognize the evaluated preparations; this does not imply superiority over other nutrient forms.
Formulation logic84
Calcium lacks its required vitamin D partner in the saved findings, limiting support for the combination.
Partner coverage
Calcium lacks its required vitamin D partner in the saved findings, limiting support for the combination.
Conflicts
No matched ingredient conflict was recorded in the supplied findings.
Effective doses
All counted ingredients meet the saved minimum amount threshold; this is not a proven fracture-prevention dose.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calcium (Calcium Hydroxyapatite) | 500 mg | |
Phosphorus (Phosphorus Hydroxyapatite) | 200 mg |
Calcium (Calcium Hydroxyapatite) · 500 mg OverallScore94
The serving supplies 500 mg of calcium. The recorded calcium source is calcium hydroxyapatite.
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
The calcium amount and its source, calcium hydroxyapatite, are identified.
Calcium Form & Absorption Potential
The recorded source is calcium hydroxyapatite.
Elemental Calcium Transparency
The stated 500 mg is the calcium amount per serving, rather than a source-compound weight.
Dose, Safety & Label Transparency84
The serving provides 500 mg of calcium. A flow agent is recorded among the other ingredients; sugar content is unavailable.
Absorption-Optimized Serving Dose
The serving supplies 500 mg of calcium.
Formulation Purity & Additives
A flow agent is recorded among the other ingredients; sugar content is unavailable.
Value100
A whole-product serving costs about $0.19 and supplies 500 mg of calcium.
Price Per Serving Efficiency
A whole-product serving costs about $0.19 and supplies 500 mg of calcium.
Phosphorus (Phosphorus Hydroxyapatite) · 200 mg OverallScore100
A serving supplies 200 mg of phosphorus as calcium hydroxyapatite. The whole-product serving costs about $0.19.
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
The phosphorus source is calcium hydroxyapatite.
Phosphorus Form Quality
The evaluation favors hydroxyapatite, but the form alone does not establish greater absorption or bone benefit.
Form Disclosure Clarity
The phosphorus ingredient row identifies calcium hydroxyapatite as its source.
Dose, Safety & Label Transparency100
The amount of phosphorus is specified as 200 mg per serving.
Dose Adequacy and Safety
A serving provides 200 mg of phosphorus.
Elemental Dose Transparency
The saved facts specify 200 mg of phosphorus itself per serving.
Value100
The whole-product serving price is relatively low.
Price Per Serving Efficiency
A serving of the whole product costs about $0.19.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- What is the impact of daily oral supplementation of vitamin D3 (cholecalciferol) plus calcium on the incidence of hip fracture in older people? A systematic review and meta-analysis.
- Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized placebo-controlled trial.
- The effects of calcium supplementation (milk powder or tablets) and exercise on bone density in postmenopausal women.
- The efficacy of calcium supplementation alone in elderly Thai women over a 2-year period: a randomized controlled trial.
- Calcium-enriched foods and bone mass growth in prepubertal girls: a randomized, double-blind, placebo-controlled trial.
- Dairy product consumption, eating habits, sedentary behaviour and physical activity association with bone mineral density among adolescent boys: a cross-sectional observational study.
- Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase 3, Single-Arm, International Trial.
- Early high calcium and phosphorus intake by parenteral nutrition prevents short-term bone strength decline in preterm infants.
- Phosphate Metabolism in Health and Disease.
- Expert consensus on clinical management of metabolic bone disease of prematurity (2021).